Horizon Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,453
Closed -$768K 456
2019
Q2
$768K Buy
5,453
+365
+7% +$50.4K 0.02% 178
2019
Q1
$768K Buy
5,088
+2,507
+97% +$361K 0.03% 184
2018
Q4
$321K Sell
2,581
-1,953
-43% -$267K 0.02% 177
2018
Q3
$719K Buy
+4,534
New +$686K 0.02% 175
2016
Q1
Sell
-3,814
Closed -$431K 105
2015
Q4
$431K Buy
3,814
+334
+10% +$36K 0.03% 67
2015
Q3
$353K Sell
3,480
-2,906
-46% -$346K 0.03% 65
2015
Q2
$792K Buy
6,386
+134
+2% +$16.2K 0.06% 52
2015
Q1
$739K Buy
6,252
+426
+7% +$48.2K 0.07% 58
2014
Q4
$594K Sell
5,826
-1,705
-23% -$167K 0.06% 55
2014
Q3
$691K Sell
7,531
-151
-2% -$13.1K 0.07% 48
2014
Q2
$632K Sell
7,682
-457
-6% -$34.9K 0.08% 61
2014
Q1
$624K Sell
8,139
-402
-5% -$31.4K 0.08% 59
2013
Q4
$591K Sell
8,541
-684
-7% -$44.9K 0.09% 51
2013
Q3
$598K Sell
9,225
-796
-8% -$50.3K 0.14% 41
2013
Q2
$583K Buy
+10,021
New +$572K 0.17% 39

Other funds holding FBT

Horizon Investments's FBT Position: Q3 2019 in Review

Horizon Investments sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 5,453 shares — an estimated $768K sold.

Horizon Investments first reported a position in FBT in Q2 2013 and held it in 15 quarters. The position peaked at $792K in Q2 2015. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

  • Horizon Investments reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
  • Horizon Investments sold 5,453 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $768K.
  • Horizon Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 15 quarters.
  • Horizon Investments's First Trust NYSE Arca Biotechnology Index Fund position peaked at $792K in Q2 2015.
  • 188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Horizon Investments's 13F filing for Q3 2019, filed 14 Nov 2019.